El Segundo, CA, United States of America

Bing Song

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Albunext, LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bing Song. Retrieved from https://idiyas.com/inventor/bing-song-hlsh7apt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Bing Song

Introduction

Bing Song is a notable inventor based in El Segundo, California. He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic agents. With a total of 2 patents to his name, his work continues to impact the industry.

Latest Patents

Bing Song's latest patents include the "Albumin Bound Macromolecule Tri-Agonist Activating GLP-1/GIP/Glucagon Receptors" and "Albumin Bound Macromolecule Tri-Agonist Activating GLP 1/GIP/Glucagon Receptors And Methods Therefor." These patents reflect his commitment to advancing medical science and improving treatment options for various conditions.

Career Highlights

Bing Song is currently employed at Albunext, LLC, where he applies his expertise in developing groundbreaking therapies. His work at the company showcases his dedication to innovation and the pursuit of excellence in the biotechnology sector.

Collaborations

Bing Song has collaborated with esteemed professionals in the field, including Patrick Soon-Shiong and Martin Robitaille. These partnerships highlight his ability to work alongside other leading experts to drive forward-thinking solutions.

Conclusion

Bing Song's contributions to biotechnology through his patents and collaborations demonstrate his significant role as an inventor. His work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…